ATE204255T1 - Carbostyrilderivate als antithrombotische mittel - Google Patents

Carbostyrilderivate als antithrombotische mittel

Info

Publication number
ATE204255T1
ATE204255T1 AT96932816T AT96932816T ATE204255T1 AT E204255 T1 ATE204255 T1 AT E204255T1 AT 96932816 T AT96932816 T AT 96932816T AT 96932816 T AT96932816 T AT 96932816T AT E204255 T1 ATE204255 T1 AT E204255T1
Authority
AT
Austria
Prior art keywords
antithrbotic
agents
carbostyril derivatives
carbostyril
derivatives
Prior art date
Application number
AT96932816T
Other languages
English (en)
Inventor
Yasuo Koga
Yoshito Kihara
Minoru Okada
Matsushige-Cho
Takao Nishi
Yoshihiro Inoue
Yukio Kimura
Hiroyoshi Hidaka
Norio Fukuda
Original Assignee
Western Therapeutics Inst D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Western Therapeutics Inst D filed Critical Western Therapeutics Inst D
Application granted granted Critical
Publication of ATE204255T1 publication Critical patent/ATE204255T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT96932816T 1995-10-05 1996-10-04 Carbostyrilderivate als antithrombotische mittel ATE204255T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25870595 1995-10-05
PCT/JP1996/002892 WO1997012869A1 (en) 1995-10-05 1996-10-04 Carbostyril derivatives as antithrombotic agents

Publications (1)

Publication Number Publication Date
ATE204255T1 true ATE204255T1 (de) 2001-09-15

Family

ID=17323960

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96932816T ATE204255T1 (de) 1995-10-05 1996-10-04 Carbostyrilderivate als antithrombotische mittel

Country Status (13)

Country Link
US (1) US6143763A (de)
EP (1) EP0796248B1 (de)
KR (1) KR100230639B1 (de)
CN (1) CN1131213C (de)
AR (1) AR004686A1 (de)
AT (1) ATE204255T1 (de)
AU (1) AU690861B2 (de)
CA (1) CA2207185C (de)
DE (1) DE69614503T2 (de)
ES (1) ES2162655T3 (de)
MX (1) MX9704145A (de)
TW (1) TW338037B (de)
WO (1) WO1997012869A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ505921A (en) 1998-03-31 2003-08-29 Warner Lambert Co 1-[5-(2,6-Dimethylpiperidino)pentyl] substituted quinolone serine protease inhibitors and their use for treating thrombin related disorders
EP1714654A4 (de) * 2004-02-09 2011-02-16 Nissan Chemical Ind Ltd Arzneimittel zur hemmung von vaskulärer intimahyperplasie
PL1894576T3 (pl) * 2005-06-08 2011-10-31 Kowa Co Nowy środek do obniżania poziomu triglicerydów
TWI481601B (zh) 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
US8796447B2 (en) 2009-08-21 2014-08-05 Otsuka Pharmaceutical Co., Ltd. Process for producing benzo[B][1,4]diazepine-2,4-dione compound
EP2801361A4 (de) 2012-01-05 2015-11-18 Kowa Co Förderer zur entwicklung einer kollateralen blutzirkulation
US11166948B2 (en) 2017-09-13 2021-11-09 National University Corporation Hamamatsu University School Of Medicine Pharmaceutical composition for treatment of aortic aneurysm
US20220184058A1 (en) 2019-03-13 2022-06-16 National University Corporation Hamamatsu University School Of Medicine Pharmaceutical composition for treating aortic aneurysm
GB202019475D0 (en) 2020-12-10 2021-01-27 Cancer Research Tech Ltd Therapeutic compounds and their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930702307A (ko) * 1991-08-23 1993-09-08 오오쓰까 아끼히꼬 카르보스티릴 유도체 및 혈소판 응집 억제제

Also Published As

Publication number Publication date
EP0796248A1 (de) 1997-09-24
EP0796248B1 (de) 2001-08-16
AR004686A1 (es) 1999-03-10
KR100230639B1 (ko) 1999-11-15
TW338037B (en) 1998-08-11
US6143763A (en) 2000-11-07
ES2162655T3 (es) 2002-01-01
DE69614503T2 (de) 2002-04-11
CA2207185A1 (en) 1997-04-10
CA2207185C (en) 2008-08-19
AU690861B2 (en) 1998-04-30
AU7145796A (en) 1997-04-28
WO1997012869A1 (en) 1997-04-10
CN1131213C (zh) 2003-12-17
HK1002194A1 (en) 1998-08-07
DE69614503D1 (en) 2001-09-20
MX9704145A (es) 1997-09-30
CN1172478A (zh) 1998-02-04

Similar Documents

Publication Publication Date Title
ATE229944T1 (de) Benzooxazine als antimikrobielle mittel
DE69713441D1 (de) N-Benzyl-2-phenylindole als östrogene Mittel
DE69930518D1 (de) Als antikrebsmittel verwendbare alkinyl-substituierte chinolin-2-on-derivate
DE59608798D1 (de) Endoparasitizide mittel
ATE277925T1 (de) Pleuromutlin-derivate als antimikrobielles wirkungsmittel
DE69634416D1 (de) Chinolin-derivate
DE69628334D1 (de) Chinolin derivate als nk3 antagoniste
DE69814349D1 (de) Befeuchtendes mittel
ATE219490T1 (de) Indazoleamid-verbindungen als serotoninergene mittel
DE69717630D1 (de) 3-phenyl-furan-(5h)-2-on- und dihydrofuran-2-on-derivate als antibakterielle mittel
DE69520235D1 (de) Schweisshemmende mittel
DE69528445D1 (de) Anti-mikrobielles Mittel
ATE226203T1 (de) Azabicycliache carbamoyloxy mutilin derivate als antibakterielles mittel
ATE254917T1 (de) Mittel gegen parasitäre protozoen
ATE189807T1 (de) N-acyl-2-arylcyclopropylmethylamin-derivate als melatonergisches mittel
EP0778847A4 (de) Immunstimulierende mittel
DK0833820T3 (da) Benzisoxazol- og indazolderivater som antipsykotiske midler
DE69921983D1 (de) Indolderivate als serotonergische mittel
DE69501421D1 (de) Hematetrenome Derivat als antiarteriosklerotisches Mittel
DE69627332D1 (de) Verbesserte phenolische vorvernetzungshemmende mittel
ATE192428T1 (de) Nitro-benzamides verwendbar als antiarrythmica
DE69221114D1 (de) Sulfonimidamide als antineoplastische Mittel
ATE187165T1 (de) Benzophenonhydrazon-derivate als insektizide
ATE236150T1 (de) (4-piperidinyl)-1h-2-benzopyran derivate verwendbar als antipsychotische mittel
DE69620313D1 (de) Als antimikrobielles Mittel verwendbare Zusammensetzung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner